EGIOEdgio, Inc.

Nasdaq edg.io


$ 10.16 $ 0.24 (2.42 %)    

Monday, 29-Apr-2024 15:50:24 EDT
QQQ $ 433.04 $ 1.75 (0.41 %)
DIA $ 383.81 $ 1.49 (0.39 %)
SPY $ 510.06 $ 1.80 (0.35 %)
TLT $ 88.99 $ 0.74 (0.84 %)
GLD $ 216.18 $ -0.44 (-0.2 %)
$ 10.17
$ 10.16
$ 0.00 x 0
$ 0.00 x 0
$ 10.05 - $ 10.46
$ 6.67 - $ 44.00
58,048
na
56.86M
$ 0.82
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-16-2023 09-30-2023 10-Q
2 09-12-2023 06-30-2023 10-Q
3 08-15-2023 03-31-2023 10-Q
4 06-29-2023 12-31-2022 10-K
5 11-09-2022 09-30-2022 10-Q
6 08-09-2022 06-30-2022 10-Q
7 04-29-2022 03-31-2022 10-Q
8 02-17-2022 12-31-2021 10-K
9 11-05-2021 09-30-2021 10-Q
10 08-02-2021 06-30-2021 10-Q
11 04-30-2021 03-31-2021 10-Q
12 02-12-2021 12-31-2020 10-K
13 10-23-2020 09-30-2020 10-Q
14 07-20-2020 06-30-2020 10-Q
15 04-24-2020 03-31-2020 10-Q
16 01-30-2020 12-31-2019 10-K
17 10-17-2019 09-30-2019 10-Q
18 07-18-2019 06-30-2019 10-Q
19 04-18-2019 03-31-2019 10-Q
20 02-01-2019 12-31-2018 10-K
21 10-19-2018 09-30-2018 10-Q
22 07-20-2018 06-30-2018 10-Q
23 04-20-2018 03-31-2018 10-Q
24 02-08-2018 12-31-2017 10-K
25 10-19-2017 09-30-2017 10-Q
26 07-27-2017 06-30-2017 10-Q
27 04-25-2017 03-31-2017 10-Q
28 02-17-2017 12-31-2016 10-K
29 10-27-2016 09-30-2016 10-Q
30 08-03-2016 06-30-2016 10-Q
31 04-28-2016 03-31-2016 10-Q
32 02-11-2016 12-31-2015 10-K
33 11-04-2015 09-30-2015 10-Q
34 08-04-2015 06-30-2015 10-Q
35 05-01-2015 03-31-2015 10-Q
36 02-17-2015 12-31-2014 10-K
37 11-10-2014 09-30-2014 10-Q
38 08-05-2014 06-30-2014 10-Q
39 05-07-2014 03-31-2014 10-Q
40 02-20-2014 12-31-2013 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 craig-hallum-maintains-hold-on-edgio-lowers-price-target-to-10

Craig-Hallum analyst Jeff Van Rhee maintains Edgio (NASDAQ:EGIO) with a Hold and lowers the price target from $30 to $10.

 citron-research-posts-on-x-egio-lets-clear-up-some-misconceptions-yesterday-a-note-was-put-out-by-an-analyst-challenging-our-thesis-we-maintain-the-company-will-be-bought-at-a-significant-premium-to-here-1--egio-is-a-significant-player-in-the-cdn-space-which-is-crucial-for-edge-computing-and-the-future-of-ai

https://twitter.com/CitronResearch/status/1780584023590355188 $EGIO Let's clear up some misconceptions. Yesterday a note wa...

 top-4-tech-stocks-you-may-want-to-dump-in-april

As of April 16, 2024, four stocks in the information technology sector could be flashing a real warning to investors who value ...

 why-ultragenyx-pharmaceutical-shares-are-trading-lower-by-around-9-here-are-other-stocks-moving-in-mondays-mid-day-session

Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new d...

Core News & Articles

Edgio Collaborates for Data Offloading CapabilitiesSinclair, Inc. (NASDAQ:SBGI) announced the launch of its "Broadspan"...

Core News & Articles

https://twitter.com/CitronResearch/status/1779873794338799911  

 watching-shares-of-edgio-citron-research-tweets-egio-is-still-the-most-compelling-valuation-in-edge

https://twitter.com/CitronResearch/status/1778860688296783980

 citron-research-posts-on-x-egio--edge-computing-is-in-the-industrys-spotlight-with-recent-announcements-from-dell-smci-amd-and-intc-despite-a-challenging-stock-performance-egio-has-reported-record-revenue-and-has-one-of-the-largest-edge-networks-in-the-world-edgio-shares-move-higher

https://twitter.com/CitronResearch/status/1778441915257549228 

 edgio-receives-expected-notice-from-nasdaq-stating-that-the-company-is-not-in-compliance-with-the-requirements-for-continued-listing-under-nasdaq-listing-rule-5250c1

Edgio, Inc. (NASDAQ:EGIO) (the "Company"), today announced that it received an expected notice (the "Notice") o...

 why-lifecore-biomedical-shares-are-trading-lower-by-around-32-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) fell sharply during Wednesday’s session after the company announced it con...

 da-davidson-maintains-neutral-on-edgio-lowers-price-target-to-7

DA Davidson analyst Rudy Kessinger maintains Edgio (NASDAQ:EGIO) with a Neutral and lowers the price target from $8.5 to $7.

 reachtv-chooses-edgio-to-help-deliver-and-monetize-streaming-content-to-airports-across-north-america

Managed Services, Event Support, Scalable Workflow, and Powerful Tools Enable Expansion and Monetization of ContentEdgio, the p...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION